Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital April 17, 2026
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress April 16, 2026
Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation April 15, 2026
Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement April 14, 2026